Here, high 68Ga-MY6349 uptake was also found in prostate and thyroid cancer; this may lead to new indications for Trop2-targted ADCs, particularly for metastatic castration-resistant prostate cancer (mCRPC) and RAIR-DTC. The gene discussed is TACSTD2; the disease is thyroid cancer.